We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Growing Body of Evidence Supports Role of Apples in Suppressing Breast Cancer

By LabMedica International staff writers
Posted on 12 Mar 2009
Six studies recently conducted add to the growing amount of evidence that an apple a day--as well as daily servings of other fruits and vegetables--can help keep the breast-cancer doctor away.

In a recent study, published in the December 10, 2009, issue of the Journal of Agricultural and Food Chemistry, Dr. More...
Rui Hai Liu, Cornell University (Ithaca, NY, USA) associate professor of food science and a member of Cornell's Institute for Comparative and Environmental Toxicology, reported that fresh apple extracts considerably inhibited the size of mammary tumors in rats--and the more extracts they were given, the greater the inhibition.

"We not only observed that the treated animals had fewer tumors, but the tumors were smaller, less malignant, and grew more slowly compared with the tumors in the untreated rats,” said Dr. Liu, pointing out that the study confirmed the findings of his preliminary study in rats published in the same journal March 21, and May 8, 2007.

In his latest study, for example, Dr. Liu found that a type of adenocarcinoma--a highly malignant tumor and the main cause of death of breast cancer patients, as well as of animals with mammary cancer--was evident in 81% of tumors in the control animals. However, it developed in only 57%, 50%, and 23% of the rats fed low, middle, and high doses of apple extracts (the equivalent of one, three, and six apples a day in humans, respectively), respectively, during the 24-week study. "That reflects potent antiproliferative [rapid decrease] activity,” he said.

The studies highlight the important role of phytochemicals, known as phenolics or flavonoids, found in apples and other fruits and vegetables. Of the top 25 fruits consumed in the United States, Dr. Liu reported in the same journal August 14, 2009, that apples provide 33% of the phenolics that Americans consume annually.

In a study of apple peel published in the Journal of Agricultural and Food Chemistry October 2, 2009, Dr. Liu reported on a variety of new phenolic compounds that he discovered that also have "potent antioxidant and antiproliferative activities” on tumors. Moreover, in yet another study in the same journal October 2, 2008, he reported on his discovery of the specific modulation effects that apple extracts have on cell cycle machinery. Recently, Dr. Liu's group also reported the finding that apple phytochemicals inhibit an important inflammation pathway (NFkB) in human breast cancer cells.

Dr. Liu concluded, "These studies add to the growing evidence that increased consumption of fruits and vegetables, including apples, would provide consumers with more phenolics, which are proving to have important health benefits. I would encourage consumers to eat more and a wide variety of fruits and vegetables daily.”

Related Links:

Cornell University




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.